The F-box Protein FBXO7 Positively Regulates Bone Morphogenetic Protein-mediated Signaling Through Lys-63-specific Ubiquitination of Neurotrophin Receptor-interacting MAGE (NRAGE)

Overview

Journal Cell Mol Life Sci

Publisher Springer

Specialty Biology

Date 2014 Jun 21

PMID 24947323

Citations 20

Authors

Jengmin Kang

Kwang Chul Chung

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease (PD) is characterized by progressive midbrain dopaminergic neuron degeneration and the formation of intracellular protein aggregates, referred to as Lewy bodies. F-box only protein 7 (FBXO7) gene mutations are closely associated with progression of the autosomal recessive form of familial PD. FBXO7 encodes a component of Skp1, cullin, F-box ubiquitin ligase complexes; however, its cellular targets, including substrates and regulators, are not yet clarified. To identify potential substrates of FBXO7, we performed a yeast two-hybrid screen of a human fetal brain library and identified neurotrophin receptor-interacting MAGE protein (NRAGE) as a novel FBXO7-binding partner. We found that FBXO7 interacts with NRAGE and mediates Lys-63-linked poly-ubiquitination of NRAGE in mammalian cells. FBXO7 overexpression accelerates formation of NRAGE-TAK1-TAB1 complexes, whereas FBXO7 knockdown correspondingly decreases complex formation. In addition, BMP4 stimulation enhances NRAGE ubiquitination through FBXO7 and facilitates endogenous NRAGE-TAK1-TAB1 complex formation. Furthermore, FBXO7 positively regulates formation of the BMP receptor-NRAGE-TAK1-TAB1 complex, and up-regulates NF-κB activity. Taken together, our results suggest that FBXO7 affects BMP4-mediated signaling through proteasome-independent ubiquitination of NRAGE and augments formation of downstream signaling components.

Citing Articles

USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7.

Lee S, Chung K PLoS One. 2023; 18(10):e0290371.

PMID: 37874827 PMC: 10597484. DOI: 10.1371/journal.pone.0290371.

FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2-Mediated Alternative Splicing.

Li S, Chen Y, Xie Y, Zhan H, Zeng Y, Zeng K Adv Sci (Weinh). 2023; 10(33):e2303561.

PMID: 37822160 PMC: 10667838. DOI: 10.1002/advs.202303561.

The deficiency of Maged1 attenuates Parkinson's disease progression in mice.

Wang J, Xu S, Ye Z, Sun Z, Zhang J, Qi C Mol Brain. 2023; 16(1):22.

PMID: 36774489 PMC: 9921624. DOI: 10.1186/s13041-023-01011-3.

Post-translational modifications on the retinoblastoma protein.

Zhou L, Ng D, Yam J, Chen L, Tham C, Pang C J Biomed Sci. 2022; 29(1):33.

PMID: 35650644 PMC: 9161509. DOI: 10.1186/s12929-022-00818-x.

FBXO7 triggers caspase 8-mediated proteolysis of the transcription factor FOXO4 and exacerbates neuronal cytotoxicity.

Lee S, Jung S, Lee Y, Hyun M, Chung K J Biol Chem. 2021; 297(6):101426.

PMID: 34800438 PMC: 8665361. DOI: 10.1016/j.jbc.2021.101426.

References

Nelson D, Laman H . A Competitive binding mechanism between Skp1 and exportin 1 (CRM1) controls the localization of a subset of F-box proteins. J Biol Chem. 2011; 286(22):19804-15. PMC: 3103358. DOI: 10.1074/jbc.M111.220079. View

Di Fonzo A, Dekker M, Montagna P, Baruzzi A, Yonova E, Correia Guedes L . FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology. 2008; 72(3):240-5. DOI: 10.1212/01.wnl.0000338144.10967.2b. View

Sang M, Wang L, Ding C, Zhou X, Wang B, Wang L . Melanoma-associated antigen genes - an update. Cancer Lett. 2010; 302(2):85-90. DOI: 10.1016/j.canlet.2010.10.021. View

Seeger M, Hartmann-Petersen R, Wilkinson C, Wallace M, Samejima I, Taylor M . Interaction of the anaphase-promoting complex/cyclosome and proteasome protein complexes with multiubiquitin chain-binding proteins. J Biol Chem. 2003; 278(19):16791-6. DOI: 10.1074/jbc.M208281200. View

Zhao T, de Graaff E, Breedveld G, Loda A, Severijnen L, Wouters C . Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15). PLoS One. 2011; 6(2):e16983. PMC: 3037939. DOI: 10.1371/journal.pone.0016983. View

Craig K, Tyers M . The F-box: a new motif for ubiquitin dependent proteolysis in cell cycle regulation and signal transduction. Prog Biophys Mol Biol. 1999; 72(3):299-328. DOI: 10.1016/s0079-6107(99)00010-3. View

Matluk N, Rochira J, Karaczyn A, Adams T, Verdi J . A role for NRAGE in NF-kappaB activation through the non-canonical BMP pathway. BMC Biol. 2010; 8:7. PMC: 2829509. DOI: 10.1186/1741-7007-8-7. View

Kirk R, Laman H, Knowles P, Murray-Rust J, Lomonosov M, Meziane E . Structure of a conserved dimerization domain within the F-box protein Fbxo7 and the PI31 proteasome inhibitor. J Biol Chem. 2008; 283(32):22325-35. DOI: 10.1074/jbc.M709900200. View

Olanow C, Tatton W . Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci. 1999; 22:123-44. DOI: 10.1146/annurev.neuro.22.1.123. View

10.

Schulman B, Carrano A, Jeffrey P, Bowen Z, Kinnucan E, Finnin M . Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature. 2000; 408(6810):381-6. DOI: 10.1038/35042620. View

11.

Kendall S, Battelli C, Irwin S, Mitchell J, Glackin C, Verdi J . NRAGE mediates p38 activation and neural progenitor apoptosis via the bone morphogenetic protein signaling cascade. Mol Cell Biol. 2005; 25(17):7711-24. PMC: 1190310. DOI: 10.1128/MCB.25.17.7711-7724.2005. View

12.

Ye Y, Blaser G, Horrocks M, Ruedas-Rama M, Ibrahim S, Zhukov A . Ubiquitin chain conformation regulates recognition and activity of interacting proteins. Nature. 2012; 492(7428):266-70. PMC: 3605796. DOI: 10.1038/nature11722. View

13.

Elsasser S, Gali R, Schwickart M, Larsen C, Leggett D, Muller B . Proteasome subunit Rpn1 binds ubiquitin-like protein domains. Nat Cell Biol. 2002; 4(9):725-30. DOI: 10.1038/ncb845. View

14.

Miranda M, Sorkin A . Regulation of receptors and transporters by ubiquitination: new insights into surprisingly similar mechanisms. Mol Interv. 2007; 7(3):157-67. DOI: 10.1124/mi.7.3.7. View

15.

Rochira J, Matluk N, Adams T, Karaczyn A, Oxburgh L, Hess S . A small peptide modeled after the NRAGE repeat domain inhibits XIAP-TAB1-TAK1 signaling for NF-κB activation and apoptosis in P19 cells. PLoS One. 2011; 6(7):e20659. PMC: 3138748. DOI: 10.1371/journal.pone.0020659. View

16.

Di Certo M, Corbi N, Bruno T, Iezzi S, De Nicola F, Desantis A . NRAGE associates with the anti-apoptotic factor Che-1 and regulates its degradation to induce cell death. J Cell Sci. 2007; 120(Pt 11):1852-8. DOI: 10.1242/jcs.03454. View

17.

Kendall S, Goldhawk D, Kubu C, Barker P, Verdi J . Expression analysis of a novel p75(NTR) signaling protein, which regulates cell cycle progression and apoptosis. Mech Dev. 2002; 117(1-2):187-200. DOI: 10.1016/s0925-4773(02)00204-6. View

18.

Shojaee S, Sina F, Banihosseini S, Kazemi M, Kalhor R, Shahidi G . Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. Am J Hum Genet. 2008; 82(6):1375-84. PMC: 2427312. DOI: 10.1016/j.ajhg.2008.05.005. View

19.

Chang Y, Cheng C, Chang L, Jong Y, Yuo C . The F-box protein Fbxo7 interacts with human inhibitor of apoptosis protein cIAP1 and promotes cIAP1 ubiquitination. Biochem Biophys Res Commun. 2006; 342(4):1022-6. DOI: 10.1016/j.bbrc.2006.02.061. View

20.

Burchell V, Nelson D, Sanchez-Martinez A, Delgado-Camprubi M, Ivatt R, Pogson J . The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy. Nat Neurosci. 2013; 16(9):1257-65. PMC: 3827746. DOI: 10.1038/nn.3489. View